CSPC Pharmaceutical receives USD 10 million AstraZeneca milestone payment under research pact - AZN News | RalliesCSPC Pharmaceutical receives USD 10 million AstraZeneca milestone payment under research pact
A
AZN• Milestone payment under research collaboration
- CSPC received a USD 10 million milestone payment from AstraZeneca on Aug. 5, 2026 under their strategic research collaboration.
- Payment followed AstraZeneca’s exercise of a license option for one preclinical candidate program.
- Collaboration covers discovery of oral small-molecule preclinical candidates across multiple targets.
